Market Research Blog – Page 11274 – New Product Development

Extracorporeal Membrane Oxygenation Machine Market reaching a valuation of US$ 908 Bn by the end of 2032

[311 Pages Report] The extracorporeal membrane oxygenation systems market is progressing steadily with a CAGR of 5% from 2022-2032, as per the extracorporeal membrane oxygenation systems market analysis by Future Market Insights (FMI).

Recent developments in extracorporeal membrane oxygenation systems market innovations such as miniaturization of ECMO components like hollow pumps, which are used in various surgeries, aids in the transportation of critically ill patients, thereby increasing the ECOM systems market size.

As per the ECOM systems market study, the rising use of ECMO has sparked technological advancements in extracorporeal membrane oxygenation machines of which oxygenators and heparin-coated cannulas are two major emerging trends in the ECOM systems market.

The study finds that extracorporeal membrane oxygenation devices are used in life-threatening situations when other forms of supportive care have failed. Furthermore, the use of ECMO in various healthcare settings has increased significantly owing to its wide range of applications.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14300

The adoption of ECMO procedures is being promoted by several government organizations. One of them is GOLD (Global Initiative for Chronic Obstructive Lung Disease), a campaign that aims to raise awareness about COPD and its treatment, which includes the use of ECMO oxygen machine thereby positively influencing the ECMO systems adoption trends.

The sudden spike in COVID-19 cases, combined with an increase in the number of critically ill patients requiring additional life support, has pushed up demand for ECMO machines. For patients with severe acute respiratory distress syndrome, extracorporeal membrane oxygenation therapy has been the preferred treatment option.

An increasing number of supportive government policies and the rapid FDA approval of extracorporeal membrane oxygenation equipment for emergency use have significantly increased the ECOM systems market opportunities.

Moreover, several companies are scaling up ECOM systems’ market share by expanding their manufacturing capabilities to meet the rising demand for assistive technologies.

On account of the factors mentioned above, the ECOM systems market is predicted to muster a revenue of about US$ 673 Mn by 2026.

Key Takeaways:

By application, high demand for early diagnosis and diagnostic imaging, and technological advancements in the extracorporeal membrane oxygenation machine market are expected to propel the respiratory segment to the top.
The arterio-venous segment is likely to hold the majority of the market based on modality owing to the benefits associated with this technology segment, such as effective dynamic range, thereby boosting the ECMO systems market growth.
Based on patient type, the adult segment is projected to lead the market as the global burden of cardiac and respiratory diseases in adults is rising due to increased consumption of alcohol, tobacco, smoking, and a sedentary lifestyle.
Based on components, the controller’s segment is expected to dominate the market, and the same can be credited to the systems’ higher adoption among end-users as a result of their lower cost when compared to others.
The portable ECMO machine segment is expected to dominate the market by product type. They are lightweight and portable, allowing them to be transported to any desired location, influencing the ECMO systems market future trends.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-14300

“North American market is anticipated to be at the forefront of the ECMO systems market because of the presence of key players and the rising number of product launches, government support for high-quality healthcare which is also considered to be a few crucial ECMO systems market trends and the rising prevalence of diseases in the United States and Canada, such as chronic obstructive pulmonary disease resulting in increased hospital admission favoured by reimbursement policies, is expected to boost the sales of ECMO systems in this region.” asserts an FMI analyst.

Competitive Landscape:Companies like Abbott Laboratories, Medtronic, Alung Technologies, and Terumo Corporation dominate the global market.

Major global players produce the majority of ECMO support systems. Market leaders have established their position by investing more in research and having a better distribution system.

To stay competitive in the market, extracorporeal membrane oxygenation machines manufacturers are actively involved in product launches and technological innovation.

ALung Technologies, Inc. has begun commercialization of its ground-breaking next-generation artificial lung. The device is based on University of Pittsburgh intellectual property licensed to ALung Technologies, Inc.
Medtronic has released its artificial lung therapy for the treatment of COVID-19. An artificial pump that pumps blood from a person’s body to an oxygenator is called ECMO, and it also has an FDA-approved device for ECMO procedures lasting up to 6 hours.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-14300

Key Segments By Product:

ECMO Machines
- Portable Devices
- Static Devices
Software

By Service Type:

Application
Middleware
Infrastructure

By Component:

Pumps
Oxygenators
Controllers
Cannul
Assessories

By Modality:

Veno-Venous
Veno-Arterials
Arterio-Venous

By Patient Type:

Neonates
Pediatrics
Adults

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Corrugated Automotive Packaging Market Expected to Witness High Growth by 2030

According to a recent report by Future Market Insights (FMI) the market for corrugated automotive packaging is likely to reflect moderate growth from 2020 to 2030. The sector is expected to benefit from sustainability initiatives in the packaging industry. The growth trajectory of the global corrugated automotive packaging market is projected to be significantly affected throughout 2020. A substantial dip in comparison to previous years is likely, largely owing to the effects of the coronavirus pandemic on the global automotive sector.

According to the report applications of corrugated packaging will primarily find use for lighting components, owing to safety standards associated with electronic parts, with boxes remaining a popular option for efficient logistical supply chain operations. The market is expected to gain from industry acquisition and capacity expansion strategies and investments towards product development.

In addition, continued demand for plastic and foam based corrugated packaging and increased niche applications for engine and battery components are likely to aid the industry for years to come. On the other hand, strict regulations about automotive component standards in terms of safety and the environment will restrict industry prospects. Also, high capital costs in the industry are expected to restrict market developments to large scale players.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-11375

The FMI report provides an overview of the industry, covering key dynamics in the market. Some of the top takeaways of the report include:

The corrugated automotive packaging market has been valued at over US$ 1.7 billion in 2019, and the growth rate of the market is likely to be strongly affected by the covid-19 outbreak, owing to lockdown restrictions on the manufacturing and automotive sectors
Corrugated boxes remain the preferred packaging format, owing to benefits in stacking, and efficiency in logistical operations from suppliers to end users
Packaging for automotive lighting will generate higher demand as that of batteries, engine components, filters, and electrical among others. Engine and battery packaging applications are likely to reflect faster growth owing to lower risk of accidental discharges

East Asia remains a leading market, supported by a vast automotive industry and numerous packaging material manufacturing facilities. Further, South Asia is also expected to be a key contributor on the back of demand from India, Indonesia, and Thailand.

“Original equipment manufacturers (OEMs) in the automotive industry are displaying increased preference towards corrugated packaging options owing to easier recycling, lower costs of shipping, and low weight. Corrugated packaging products are easier to customize as per the needs of the end user through the supply chain,” said a lead analyst at FMI.

Covid-19 Effect on Corrugated Automotive Packaging Market

The coronavirus outbreak has had a largely negative impact on the corrugated automotive packaging industry. Lockdown restrictions on the automotive, manufacturing, and packaging sectors will result in a sharp decline in demand.

Also, restrictions imposed on international trade in terms of raw materials and components and restricted operations at production plants are likely to have a disruptive impact on the market in the short term. Recovery is likely to be sluggish owing to uncertainty over duration and severity of the outbreak, with growth likely to rise through 2021.

Request Customization @

https://www.futuremarketinsights.com/customization-available/rep-gb-11375

Who is Winning?

In its latest report, Future Market Insights has given a detailed analysis of the many strategies being employed by market players in the corrugated automotive packaging market. Leading players are largely emphasizing on product development and launch strategies in addition to strategic acquisitions and capacity expansions.

Some of the major players in the industry include International Paper Company, Sonoco Products Company, Mondi Group Plc, Sealed Air Corp, WestRock Company, Greif Inc., DS Smith plc, and Smurfit Kappa Group plc, among others.

About Us

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs

Inflatable Packaging Market Estimated to Expand at a Robust CAGR By 2030

The inflatable packaging market is set to grow at a steady pace through 2030, as demand for convenient packaging continues to grow.

Demand will continue to be strong in the US, however, opportunities in Asia Pacific are likely to complement growth. Many economies in Asia Pacific have been less severely impacted by the COVID-19 crisis, and this can offset some of the weakness in the market.

“Advanced technologies and better preference for packaging solutions across the planet, has surged the demand for inflatable packaging. Flourishing e-commerce activities demand convenient packaging solutions to avoid shocks and damage to the product,” says the FMI Analyst.

Request a report sample to comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-12636

Inflatable Packaging Market – Key Highlights

According to analysis at FMI, bubble wrap section is anticipated to expand exponentially due to escalating demand by online retailers.
US will remain the largest market for inflatable packaging during the assessment period.
Owing to its lightweight feature, air pillow section will witness rapid adoption.

Inflatable Packaging Market – Driving Factors.

Growing demand for safe packaging is pushing inflatable packaging market growth
Air pillow section provides higher barrier protection against shocks, therefore, creating sustainable opportunities in fragile item packaging
Requirement of bubble wraps in packing fragile products for cushioning purpose, propels demand for the same.
Food, beverage and healthcare industries also require such packaging to reduce exposure and destruction.

Inflatable Packaging Market – Key Restraints

• Inflatable packaging continues to be relatively higher priced than traditional packaging.

• Reduced availability of raw materials is creating supply chain issues

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-12636

Competition Landscape

Key inflatable packaging market players are involved into incorporating innovative techniques like shock protective barriers to reinforce market growth. Some of the key players in the market include, Automatic Packaging Systems, Inc., Macfarlane cluster PLC, Polyair Interpack, Sealed Air Corporation, Pregis Corporation, Smurfit Kappa Group, Automated Packaging Solutions Inc., Macfarlane Group PLC, Polyair Interpac Inc.

Inflatable packaging manufacturers are also functioning on increasing product portfolio to get a better market insight. They are launching distinctive product and making new market technologies, mergers and acquisitions.

Intertape Polymer Group acquired Polyair Interpac to include bubble cushioning, mailers and air pillow systems and sold a variety of paper and film based packaging products.

Smurfit Kappa signed a contract with Nestle to enhance food packaging. This in turn helped in widening the supply chain and assisted in exporting products to greater distances.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/12636

About Us

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs

Eco-Friendly Straws Market Future Trends, Industry Size and Forecast to 2030

Progressing at a steady CAGR of 5.1% (2022-2030), sales of eco-friendly straws are anticipated to attain an estimated valuation of US$ 2.2 Bn by the end of 2030. At present, the global eco-friendly straws market is valued at US$ 1.5 Bn.

According to FMI, the global eco-friendly straws market is anticipated to exhibit a positive growth trend through 2030, primarily driven by growing focus on sustainable manufacturing and consumption. The report opines that awareness about sustainable living and rising environmental protection concerns will influence investments in eco-friendly products, and straws as a category will benefit from it.

Demand for eco-friendly straws is especially strong across the foodservice segment, with an increasing proportion of consumers preferring to eat fast foods and other ready-to-serve meals.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-12573

Key Takeaways

Global eco-friendly straws market to expand at 4.9% CAGR through 2030
Stringent legal provisions combined with awareness campaigns by NGOs to curb plastic waste likely to drive market growth
Virgin kraft paper to witness maximum adoption in eco-friendly straws production due to enhanced material neutrality
Sales through e-commerce channels to surpass US$ 2 Bn by 2030
Europe will witness higher investments in eco-friendly straws

“Collaborations with governmental agencies and global platforms to spread awareness about plastic waste generation is considered an important approach by vendors to promote sales of eco-friendly straws,” says the FMI analyst.

COVID-19 Impact Analysis

With the onset of the coronavirus pandemic, a definite hygiene oriented pattern has emerged within consumers’ habits. Consumers are reallocating their budgets towards purchasing immunity and hygiene enhancing foods and beverages.

This trend of healthy drinking and eating also entails utilization of environmentally friendly utensils such as paper plates, bowls, straws and cutlery. Hence, demand for eco-friendly straws in household settings has witnessed a major spike since the past few months.

The imposition of lockdowns has compelled organizations to issue work-from-home directives. Subsequently, there has been an increase in the demand for fast foods and ready-to-drink beverages through online delivery platforms. This has impelled the sales of eco-friendly straws.

A moderate downswing is anticipated with the cessation of outdoor dine-in activities. Fears of community infection spreading has compelled hotels, cafeterias and restaurants to suspend all dining operations, decelerating demand for eco-friendly straws across the commercial sector.

Request Customization @

https://www.futuremarketinsights.com/customization-available/rep-gb-12573

Competitive Landscape

Key players are focusing on expanding their reach globally by diversifying their product portfolio. They also undertake awareness campaigns to minimize usage of non-recyclable material and strategic partnerships with existing players.

In 2018, Sulapac Oy joined forces with Stora Enso to develop renewable and biodegradable straws. This partnership is a product of both companies’ commitment to combat the global problem of plastic waste generation. The straws are made from wood and natural binders, recyclable via industrial composting.

Recently, in May 2020, Huhtamaki Oyj collaborated with WasteAid and announced a global partnership to drive community level circular economy innovation in key locations. The collaboration aims to provide education and training on waste management and circular systems and work with key stakeholders across India, Vietnam and South Africa.

About Us

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs

Spinal Cord Stimulators Market is projected to be valued around US$ 5.17 billion in 2032

In terms of value, an impressive 6.4% CAGR is estimated for the global spinal cord stimulators market by a report of Future Market Insights (FMI). In 2017, the market will account for nearly US$ 2,000 Mn in revenues; by 2027 this number is estimated to reach US$ 3,568.2 Mn. Growth of the market is primarily attributed to under penetration of potential market.

Introduction of affordable devices would pave huge opportunities for the global spinal cord stimulators market across developing economies. Customized spinal cord stimulators as per the requirements of an individual is expected to offer higher growth potential for leading market players. Specialists in healthcare settings are more likely to prescribe devices that are smaller in size, owing to their easy implantation and less painful surgical procedure.

Request Sample @– https://www.futuremarketinsights.com/reports/sample/rep-gb-2030

Spinal Cord Stimulators’ Ability of Reducing Opioid Analgesics Addiction to Drive the Market Growth

Majority of patients with chronic pain are increasingly depending upon opioid analgesics; however spinal cord stimulators is capable of reducing this addiction to a great extent. Entry of additional competitors in the market is expected to increase awareness about effectiveness of spinal cord stimulators. Spinal cord stimulators are comparatively more cost-effective than conventional medical management (CMM). Leading companies in the market are taking initiatives in improving technology for spinal cord stimulators. The aforementioned factors are estimated to drive growth of the global spinal cord stimulators market.

However, spinal cord stimulators have little access to evidence-based data in order to confirm effectiveness of these devices for management of chronic pain. Clinical validation of spinal cord stimulation is based on observational data, instead of verified data. This had led several private insurance companies to refuse reimbursement of costs, which in turn is impeding the market growth. In addition, complications associated with spinal cord stimulators, such as paresthesia- characterised by burning sensation, is further expected to restrain growth of the global spinal cord stimulators market.

Rechargeable Spinal Cord Stimulators will Remain Sought-After Product in the Market

In terms of value, rechargeable spinal cord stimulators are expected to remain sought-after product in the market. Revenues amassed from sales of rechargeable spinal cord stimulators are expected to reach US$ 2,530.4 Mn by 2027-end. In addition, sales of non-rechargeable spinal cord stimulators are anticipated to expand at 4.6% CAGR through 2027. Factors such as low battery life, and requirement of surgery for replacement of battery are restricting adoption of non-rechargeable spinal cord stimulators across the globe.

Application of spinal cord stimulators will remain highest in failed back surgery syndrome (FBSS), with sales estimated to surpass US$ 1,000 Mn in 2017. In addition, complex regional pain syndrome (CRPS) is projected to be the second-fastest growing application of spinal cord stimulators in the market. In terms of value, sales of spinal cord stimulators in CRPS are estimated to register 5.8% CAGR through 2027.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2030

Adoption of Spinal Cord Stimulators to Witness Fastest Growth in Ambulatory Surgical Centres

Although hospitals will continue to be largest end-users of spinal cord stimulators, adoption will witness fastest growth in ambulatory surgical centres. Sales of spinal cord stimulators in hospitals are estimated to account for revenues worth US$ 627.9 Mn in 2017. Demand for spinal cord stimulators in ambulatory surgical centres is projected to exhibit 6.8% CAGR through 2027. In contrast, demand for spinal cord stimulators in clinics will remain sluggish in the market.

North America will continue to remain dominant in the global spinal cord stimulators market, with sales estimated to reach nearly US$ 3,000 Mn in revenues by 2027-end. Western Europe will remain the second-largest market for spinal cord stimulators, expanding at 6.1% CAGR through 2027. In addition, markets in Eastern Europe and Japan are estimated to exhibit parallel expansion at 6% CAGR through 2027.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2030

Key market players identified in FMI’s report include

Boston Scientific Corp.
Medtronic Private Limited Company
St Jude Medical LLC
Nevro Corp
Nuvectra Corporation
Stimwave
Saluda Medical PTY Limited.

Spinal Cord Stimulators Market TaxonomyRegion

North America
Latin America
Western Europe
Eastern Europe
APEJ
MEA
Japan

End User

Hospitals
Ambulatory Surgical Units
Clinics

Application

Failed Back Surgery Syndrome
Complex Regional Pain Syndrome
Ischemic Limb Pain
Others

Product Type

Rechargeable
Non-Rechargeable

About FMI:

Branded Generics Market to Witness Excellent Revenue Growth, Overview, Emerging Trends and Forecast by 2031

[280 Pages Report] ESOMAR-certified consulting firm Future Market Insights (FMI) in its latest report forecasts that the global branded generics market will register healthy growth at a CAGR of 5.8% between 2021 and 2031.

The swift growth of branded generics market can be attributed to the growing number of patent expiry of branded or blockbuster drugs along with increasing prevalence of chronic diseases. Rising demand for cheap medical treatments is positively impacting the demand in the market.

Branded generics are pharmaceutical drugs that have been re-released with a different brand name. They are used to treat various diseases such as diabetes, hypertension, back pain and others. These drugs occupy small but lucrative subset of the entire generic market

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1260

Since branded generics are free from patenting, companies are investing handsome amounts on this drug category. The market is set to reach a valuation of around 283.2 Bn in 2021, with top players in tier-1 accounting for 20%-25% market share.

The entry of new players, simple market authorization procedures, greater profit margin and off-invoice discounts will expand branded generics market during the forecast period.

As per the FMI’s analysis, despite the slight setback due to the pandemic, the global branded generics market registered year-on-year (Y-o-Y) growth at 4.9% CAGR during 2020-2021.

“Rising demand for branded generics across both developing and developed economies along with high penetration of pharmaceutical industry will offer lucrative growth opportunities for the branded generics manufacturers during the forecast period” says the FMI analyst.

Key Takeaways from FMI’s Branded Generics Market Study

China and India are spearheading the growth of Asia Pacific market spurred by the increasing adoption of branded generics by large-scale pharmacy chains in the emerging economies
The U.S. will lead the North America’s branded generics market, registering a growth at 3.83% CAGR during the forecast period.
The market in India is expected to offer lucrative growth opportunities to branded generics manufacturers backed the expansion of pharmaceutical industry
In terms of therapeutic application, cardiovascular diseases and diabetes are expected to account for considerable market share
Oral solid dose pharmaceutical formulation continues to be highly preferred among patients. The oral segment accounts for over 55% share of the global branded generics market.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1260

Competitive Landscape

Teva, Abbott Laboratories, Novartis, Mylan, Pfizer are some prominent players operating in the branded generics market cumulatively hold around 20-25% market share.

Key players operating in branded generic market are focusing on expanding their business in emerging markets. They are adopting various organic and inorganic growth strategies such as mergers and acquisitions, advanced product development and collaborations to gain a competitive edge in the market.

In October 2020, Glenmark Pharmaceuticals, introduces NINDANIB (Nintedanib) for the treatment of pulmonary fibrosis in India. Glenmark has been amongst the first to launch the branded generic version at an affordable cost for the treatment of pulmonary fibrosis in India.

More Valuable Insights on Branded Generics Market

In its latest report, FMI provides an incisive coverage on the global branded generics market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031.The study provides compelling insights on branded generics market on the basis of therapeutic application (oncology, cardiovascular diseases, diabetes, neurology, gastro intestinal diseases, dermatology diseases, analgesic and others), drug class (alkylating agents, anti-metabolites, hormones, anti-hypertensives, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics and others ), formulation type (oral, parenteral, topical, others) and distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, drug stores) across seven major regions.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1260

Branded Generics Market by Category Therapeutic Application:

Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Dermatology Diseases
Analgesics and Anti-inflammatory
Others

Drug Class:

Alkylating Agents
Antimetabolites
Hormones
Anti-Hypertensive
Lipid Lowering Drugs
Anti-Depressants
Anti-Psychotics
Anti-Epileptics
Others

Formulation Type:

Oral
Parenteral
Topical
Others

Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

About FMI:

Revision Knee Replacement Market is estimated to reach US$ 2 Billion with a CAGR of 4.1% by 2032

The market for revision knee replacements is expected to reach $1.3 billion by 2022. The revision knee replacement market is expected to reach $2 billion by 2032, with a CAGR of 4.1 percent.

Revision knee replacement also known as revision total knee arthroplasty, is a procedure in which already implanted artificial knee joint, or prosthesis is replaced with a new prosthesis. Revision knee replacement also include the use of bone grafts. The bone graft can be an autograft which is taken from the site in patient’s body or allograft where the bone tissue comes from donor.

Report Attribute	Details
Revision Knee Replacement Market Value (2022)	US$ 1.3 Billion
Revision Knee Replacement Market Anticipated Forecast Value (2032)	US$ 2 Billion
Revision Knee Replacement Market Projected Growth Rate (2022-2032)	4.1%

There are three major purpose of revision knee replacement: relieving pain in the affected area, restoring the mobility of the patient, and removing loose or damaged prosthesis. Total knee replacement surgery is most successful but over time if the fails due to various reasons then revision knee replacement is done. Revision knee replacement have the same goal to relive pain and improve function like the total knee replacement surgery.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5966

Revision knee replacement surgeries are more complex and take longer time and extensive planning and specialized implants and tools are required to achieve better results. There are various type of revision surgery. In certain cases only on implants or component is replaced. Other time all the three component- tibia, femoral and patellar needs to be replaced and the bone around the knee needs to rebuild with the metal piece or bone graft.

The major step in revision surgery is the removal of the old femoral component. After the removal of the metal shell in the femoral, damaged bone is scraped off and the femur bone is reshaped. If the bone is weak, the cavity inside the femur is filled with bone grafts.

Revision Knee Replacement Market: Drivers and Restraints

The revision knee replacement is expected to grow due to the increasing rate of old age diseases like obesity arthritis, sports related injuries, osteoporosis, diabetes and aging population and. However existing and upcoming advancement in the technology in the revision knee replacement such as minimally invasive surgery and better implant materials are the factors that drive the revision knee replacement market globally.

Increasing investment in the healthcare sector also drive the market of the revision knee replacement market. Despite the widely used procedures for curing disease the global revision knee replacement market is facing challenge such as economic slowdown which is forcing patients to reconsider elective surgeries when the conservative medical treatments such as viscosupplementation may ease the pain. High cost surgery, growing awareness for the non-surgical treatment methods such as exercise, walking aids, and weight loss inhibits the market of the revision knee replacement market.

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-5966

Revision Knee Replacement Market: Overview

Revision knee replacement market is one of the most effective and widely used to relive the pain of arteritis. Technological advancement in the knee replacement market such as minimally invasive implant materials and their success rate allowing even the younger generation to undergo revision knee replacement.

The revision knee replacement promotes technologies such as 3D printed knee implants. The emerging revision knee replacement market due to advancement in the technologies and new product launch. The manufacturing companies are raising their respective market share with the help of marketing activities and growing awareness among the people.

Revision Knee Replacement Market: Regional Outlook

The market for limb correction system are examined across the region such as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominates the revision knee replacement market due to high patient awareness, increasing healthcare expenditure and relatively larger number of research and development increase in the advancement in the technology which contribute to the revenue generation from the region.

Asia Pacific is expected to grow owing to the increasing prevalence and rapid booming medical tourism industry in the emerging economics of India and China propel the growth of the revision knee replacement market.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/5966

Revision Knee Replacement Market: Key Players

Some of the key players in the Revision Knee Replacement Market are Smith & Nephew Plc, Wright Medical Group, Inc, Zimmer Holdings, Biomet, Inc., Exactech, Stryker Corporation, DePuy Companies, Inc , B. Braun Melsungen AG, DJO Global, Ortho Development, Limacorporate S.p.a., SURGIVAL INTERNATIONAL, BEZNOSKA, s.r.o., whereas some and regional players also have a significant presence in revision knee replacement market.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Revision Knee Replacement Market: Segmentation

Tentatively, global revision knee replacement market has been segmented on the basis of product type, fixation type and end user.

Based on product type, global revision knee replacement market is segmented as below:

Three compartmental
Unicompartmental

Based on fixation type, global revision knee replacement market is segmented as below:

Cemented
Cementless

Based on end user, global revision knee replacement market is segmented as below:

Hospitals
Orthopedic and Prosthetic Clinics
Others

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

IV Infusion Gravity Bags Market is expected to be worth US$ 1281.3 million by 2032

The global IV infusion gravity bags market was worth US$ 723.8 million in 2022 and is expected to be worth US$ 1281.3 million by 2032, growing at a CAGR of 5.87 percent during the forecast period.

IV infusion gravity bags are adopted for transferring medication straight into intravenous of the patient. IV infusion gravity bags are based on gravitational pull which provides external pressure on the liquid (high height is directly proportional to higher pressure). IV infusion gravity bags are used for fast transport of liquid medication throughout the patient’s body. IV infusion gravity bags are mainly accepted for its use in fluid replacement therapies such as dehydration, electrolyte imbalance, and also for blood transfusion. IV infusion gravity bags range from 50ml to 1000ml.

In addition, IV infusion gravity bags are kept at height by hanging through IV pole. The IV infusion gravity bags mainly comprises of following parts such as drip chamber, roller clamp, slide clamp, and injection port. The working of IV infusion gravity bags are based on gravitational pressure that pushes liquid medication down through tubing/pipe into patient’s veins.

Report Attribute	Details
Estimated Base Year Value (2021)	US$ 684.15 Million
Expected Market Value (2022)	US$ 723.8 Million
Anticipated Forecast Value (2032)	US$ 1281.3 Million
Projected Growth Rate (2022-2032)	5.87% CAGR

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5108

IV Infusion Gravity Bags Market: Drivers and Restraints

The IV infusion gravity bags market shows a healthy growth during the forecast period. The factors such as increasing number chronic disorders and increasing number of surgeries on the global level are driving the growth of IV infusion gravity bags market. In addition, increasing the prevalence of malnutrition and blood transfusion processes in emerging economies are also gardening the market growth of IV infusion gravity bags. However, lack of sophisticated healthcare infrastructure and scarcity of skilled professionals in developing and under-developed regions are hindering the growth of IV infusion gravity bags market.

IV Infusion Gravity Bags Market: Overview

The IV infusion gravity bags carries infusion material for delivering into patient’s vein. The flow of medication through IV infusion gravity bags are controlled by using roller clamp device located on IV pole. IV infusion gravity bags shows a high rate of penetration owing to use in home care settings. With the increasing penetration and ease in availability through the e-commerce website is boosting the growth of IV infusion gravity bags market.

Ask for Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-5108

IV Infusion Gravity Bags Market: Region Wise Outlook

Geographically, IV infusion gravity bags market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is projected to hold the largest share of IV infusion gravity bags in the global market, followed by Western Europe, owing to increasing surgical procedures in this region.

In addition, presence of sophisticated healthcare facility, and rising prevalence of chronic and acute disorders are also gardening the growth of IV infusion gravity bags market. The market in Asia Pacific excluding Japan is anticipated to show the fastest CAGR over the forecast period owing to the presence of large population base and increasing number of hospitals and clinics. However, the market in regions such as Latin America, Eastern Europe, and Middle East and Africa show steady growth over the forecast period.

IV Infusion Gravity Bags Market: Key Players

Some of the market participants in the global IV infusion gravity bags market are Haemotronic Advanced Medical Technologies, Sippex IV Bag, Kraton Corporation, ICU Medical, Inc., Baxter International Inc., Terumo BCT Ltd., The Metrix Company, Renolit, Technoflex, and Bioteque Corporation.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-5108

Key Segments Profiled In The IV Infusion Gravity Bags Market Industry Survey

IV Infusion Gravity Bags by Material type:

Polypropylene (PP) IV Infusion Gravity Bags
Polyvinyl Chloride (PVC) IV Infusion Gravity Bags
Ethylene-Vinyl Acetate (EVA) IV Infusion Gravity Bags
Low-Density Polyethylene (LDPE) IV Infusion Gravity Bags
Others

IV Infusion Gravity Bags by Layer Type:

Single Layer IV Infusion Gravity Bags
Multiple Layer IV Infusion Gravity Bags

IV Infusion Gravity Bags by End User:

IV Infusion Gravity Bags for Hospitals
IV Infusion Gravity Bags for Clinics
IV Infusion Gravity Bags for Ambulatory surgical Centers
Others

IV Infusion Gravity Bags by Region:

North America IV Infusion Gravity Bags Market
Latin America IV Infusion Gravity Bags Market
Europe IV Infusion Gravity Bags Market
Asia Pacific IV Infusion Gravity Bags Market
MEA IV Infusion Gravity Bags Market

About FMI:

Unresectable Hepatocellular Carcinoma Market Development Status, Competition Analysis, Type and Application 2030

This Unresectable Hepatocellular Carcinoma market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape.

Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Unresectable Hepatocellular Carcinoma market.

Cancer is most common disease which has higher mortality rate. Hepatocellular Carcinoma (HCC) is an aggressive tumor disorder which occurs in patients associated with chronic liver disease and cirrhosis. In unresectable hepatocellular carcinoma, surgical and liver-directed non-surgical treatment is not appropriate.

However, systemic therapy using various methods can be used in patients suffering from unresectable hepatocellular carcinoma. Based on a study in the U.S. for every 100,000 people, there are six new cases of HCC and incidence has increased over last four decades.

Get Sample of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-11266

Unresectable Hepatocellular Carcinoma Market: Drivers and Restraints

High incidence rate of liver carcinoma is expected to drive the unresectable hepatocellular carcinoma market. Unmet market demand for new treatment options is expected to drive the unresectable hepatocellular carcinoma market. Increasing research funding by industry players is expected to fuel the growth of table hepatocellular carcinoma market.

However, the diagnosis in general population is very less and poor efficacy of current therapeutic agents may hinder the growth of unresectable hepatocellular carcinoma market.

Unresectable Hepatocellular Carcinoma Market: Overview

Unresectable hepatocellular carcinoma market has high potential due to unmet demand for patient care and huge opportunity for alternative novel treatment options. Based on the systemic treatment segmentation, chemotherapy is expected to lead unresectable hepatocellular carcinoma market in the future.

Recently in 2018, FDA approved Lenvatinib capsules (Lenvima) manufactured by Eisai Inc., which is used as a first-line of treatment for unresectable hepatocellular carcinoma. Emerging therapies are majorly focused on Ramucirumab, Cabozantinib for the treatment of unresectable hepatocellular carcinoma.

Unresectable Hepatocellular Carcinoma Market: Regional Overview

The global unresectable hepatocellular carcinoma market is expected to be dominated by North America due to high treatment adoption rate. Europe is expected to be the second most lucrative region in the global unresectable hepatocellular carcinoma market owing to higher healthcare expenditure.

Request for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-11266

Latin America is emerging region for unresectable hepatocellular carcinoma market and is estimated to show high growth owing to increasing early diagnosis of disease. East Asia and South Asia unresectable hepatocellular carcinoma market are expected to show significant growth due to improving healthcare infrastructure. Middle East and Africa is expected to be the least lucrative due to low awareness and poor economic conditions.

Unresectable Hepatocellular Carcinoma Market: Key Players

Examples of some of the market participants in unresectable hepatocellular carcinoma market identified across the value chain include Eisai Co., Ltd, Bayer AG, Bristol- Myers Squibb Company, Sumitomo Dainippon Pharma Co., Ltd, Glaxosmithkline Plc, Exelixis, Inc, Eli Lilly and Company, Merck & Co., Inc., Incyte Corp, Novartis AG, F. Hoffmann-La Roche Ltd, Astrazeneca Plc, Pfizer Inc, Celgene Corporation, Sanofi S.A., and Others.

The research report on unresectable hepatocellular carcinoma market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.

The research report on unresectable hepatocellular carcinoma market provides analysis and information according to market segments such as geographies, application, and end user.

Request Customization of the report @ https://www.futuremarketinsights.com/customization-available/rep-gb-11266

The report covers exhaust analysis on Unresectable Hepatocellular Carcinoma Market

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Report on Unresectable Hepatocellular Carcinoma Market includes regional analysis

North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina)
Europe (Germany, Italy, France, U.K, Spain, Russia)
East Asia (China, Japan, South Korea)
South Asia (India, ASEAN)
Oceania (Australia, New Zealand)
Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report on unresectable hepatocellular carcinoma market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unresectable Hepatocellular Carcinoma Market: Segmentation

The global unresectable hepatocellular carcinoma market is classified on the basis of systemic treatment, end user, and region

Why choose FMI?

With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
Market Reports researched and peer reviewed by industry experts from across the globe
We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
Primary research includes mandatory field interviews with stakeholders involved
Customizing reports according to client specification is also our forte

Unresectable Hepatocellular Carcinoma Market: Segmentation

The global unresectable hepatocellular carcinoma market is classified on the basis of systemic treatment, end user, and region

Based on systemic treatment, unresectable hepatocellular carcinoma market is segmented into the following:

Chemotherapy
Molecularly Targeted Therapy
Immunotherapy

Based on end user, unresectable hepatocellular carcinoma market is segmented into the following:

Hospitals
Specialty Clinics
Cancer Centers
Research institutes

For Read More Related Insights:

https://synkretic.mn.co/posts/26365400?utm_source=manual

https://beyondher.mn.co/posts/26365398?utm_source=manual

https://network-66643.mn.co/posts/26365337?utm_source=manual

https://thegameoflife-de.mn.co/posts/26365332?utm_source=manual

About FMI:

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Elastic therapeutic tape Market Industry Research, Segmentation, Key Players Analysis and Forecast to 2029

Elastic therapeutic tape is called as Kinesiology tape it is an elastic cotton strip consisting of acrylic adhesive which helps in pain treatment and disability from athletic injuries. It is widely used in rehabilitation and treatment of sport injuries which is triggering the growth of the elastic therapeutic tape market. For instance, rehabilitative tape helps to simplify the body’s healing process by providing its extended soft tissue manipulation.

Furthermore, these elastic therapeutic tape are also used for proprioceptive facilitation, reduction of muscle fatigue, enhanced healing & helps to relax tired muscles. Additionally, the elastic therapeutic tape can be stretched up to 140% which means it can be stretched more than normal length.

Furthermore, support to sore muscle, relief from swelling, and physiotherapy treatments are some of the features of elastic therapeutic tape that influence the market growth. It has various applications that fuel the demand of the elastic therapeutic tape market growth during the forecast period include treatment of ligament strains, joint swelling, treatment of muscle sprains arthritis, low muscle tone or weakness.

Additionally, increase in number of orthopaedic patient’s treatment is boosting the market growth elastic therapeutic tape in near future. According to studies, Elastic therapeutic tape market is expected to reach a 350 million dollar USD by 2026 from 150 million USD in 2019.

Get Sample of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10986

Elastic therapeutic tape Market: Drivers and Restraints

Increase in adoption of elastic therapeutic tape for orthopaedic treatment and rising demand for versatile and easy use of therapeutic tape are emerging trends propelling elastic therapeutic tape market growth during the forecast period. Moreover, rise in geriatric population and frequent use of tape in sports and aerobics owing to increase in minor accidents in sports are some of the major factors driving the elastic therapeutic tape market growth.

Furthermore, rise in awareness about physical disabilities coupled with growing healthcare infrastructure are the opportunities expected to experience elastic therapeutic tape market growth in near future.

However, stringent rules and regulations regarding patient rights, lack of awareness in developing countries, limited availability of high cost raw materials, and among others are some of the factors hampering the elastic therapeutic tape market growth in near future. Additionally, complications in acquiring of patents by new market entrants may hinder the Elastic therapeutic tape market growth.

Elastic therapeutic tape Market: Overview

The global elastic therapeutic tape market is expected to experience significant growth during the forecast period. After 2008 Olympics, Kinesio USA, donated 50,000 rolls of the elastic therapeutic tape to 58 participating countries which created popularity of elastic therapeutic tape market.

Request for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-10986

Major production of tape is done by companies like SpiderTech, KT TAPE, RockTape, Kinesio Taping, and Strength Tape which occupied major market share of the total revenue generated. Additionally, they are also focusing on providing these tapes at a very cost effective price which will further provide better opportunities for market elastic therapeutic tape growth during the course of period.

Elastic therapeutic tape Market: Region-wise Outlook

Geographically, the elastic therapeutic tape market is segmented on the bases of North America, Europe, Latin America, South Asia, East Asia, Oceania, Middle East and Africa. North America is dominating the market owing to increased availability of raw materials, availability of trained man power and major manufacturing company Kinesio located in USA region.

Europe is considered as second largest contributing region of the market due to increase in healthcare awareness, and among others .Asia Pacific is fastest growing regions due to rise in geriatric population, increase in adoption of different sports, government support and among others.

Elastic therapeutic tape Market: Key Market Participants

Spider tech, KT Tape, Rock Tape, Nitto Denko, kinesio tapping, Tera medical, DL medical and health, Kindmax, and Mueller.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

Request Customization of the report @ https://www.futuremarketinsights.com/customization-available/rep-gb-10986